Results 21 to 30 of about 127,921 (347)
Human Molecular Genetics, 2007 Parkinson's disease (PD) is a chronic progressive neurodegenerative movement disorder characterized by a profound and selective loss of nigrostriatal dopaminergic neurons. Clinical manifestations of this complex disease include motor impairments involving resting tremor, bradykinesia, postural instability, gait difficulty and rigidity.
Bobby, Thomas, M Flint, Beal
openaire +5 more sources
Moving Children and Adolescents
Deutsche Zeitschrift für Sportmedizin, 2019 Cerebral infarcts and haemorrhages, dementia, Parkinsons disease, sarcopenia, falls,and insomnia have in common that they frequently occur in higher ages, may considerably impair quality of life and cannot be primarily prevented by medication.
Reimers CD
doaj +1 more source
COGNITIVE AND AFFECTIVE DISORDERS AT EARLY STAGES OF PARKINSON’S DISEASE
Alʹmanah Kliničeskoj Mediciny, 2016 Background: Non-motor signs, including affective and cognitive ones, are important initial manifestations of Parkinsons disease, along with motor dysfunction. Some of them manifest even before motor disorders and affect patients’ quality of life. Aim: To
R. R. Bogdanov +2 more
doaj +1 more source
, 2021 Over the centurys, increasingly sophisticated tools have been developed to serve humanity. In many ways, digital computers are just another tool. You can perform the same number and symbol operations as ordinary people, but it is faster and more reliable.
Patel Minesh
core +1 more source
Parkinson’s disease over the last 20 years – new concepts and developments
Advances in Clinical Neuroscience & Rehabilitation, 2020 Much has changed in our understanding and approach to Parkinson’s Disease (PD). This in part is because of new scientific methods such as the discovery of how to make induced pluripotent stem cells (iPSCs); the development of improved gene editing ...
Barker, Roger
doaj +1 more source
Disease modifying treatments for Parkinson’s disease – an update
Advances in Clinical Neuroscience & Rehabilitation, 2021 An improved understanding of the pathological processes leading to neurodegeneration in Parkinson’s disease (PD) is leading to the development of a number of disease modifying agents. These include both novel and repurposed drugs.
Vijay Chandran, Donald G Grosset
doaj +1 more source
Nepal Journal of Neuroscience, 2018 We present a case of 57 years old patient with Idiopathic Parkinsons disease(PD) who had right sided Globus PallidusInternus (GPi) lesioning or pallidotomy as surgical treatment modality of PD.
Resha Shrestha +4 more
doaj +1 more source
Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
Parkinson's Disease, 2020 Purpose. Autonomic dysfunction is a common nonmotor feature and early manifestation of Parkinsons disease (PD). Autonomic dysfunction in PD is associated with a worse prognosis.
Daniel Martinez-Ramirez +8 more
doaj +1 more source
Prosody and levodopa in Parkinsons disease
Arquivos de Neuro-Psiquiatria, 2013 Objective Research is scarce regarding the use of prosodic parameters in the expression of attitudes in Parkinson’s disease (PD). The purpose of this study was to evaluate the parameters used in prosodic expression of attitudes in individuals with ...
Luciana Lemos de Azevedo +3 more
doaj +1 more source
Test-retest reliability of physical activity questionnaires in Parkinsons disease
, 2021 Background People with Parkinsons disease are less physically active than controls. It is important to promote physical activity, which can be assessed using different methods.
Ånfors, Samuel +9 more
core +1 more source